These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2000673)

  • 21. [Clinical assessments on pre-treatment prognostic factors in 138 patients with advanced prostatic carcinoma (stage D2)].
    Kato M; Okada K; Yamashina M; Tohma T; Ishiwata D; Higashi Y; Ohwada F
    Hinyokika Kiyo; 1993 Feb; 39(2):131-4. PubMed ID: 8465686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radical prostatectomy and postoperative irradiation in patients with pathological stage C (T3) carcinoma of the prostate.
    Petrovich Z; Lieskovsky G; Langholz B; Formenti S; Baert L; Streeter O; Skinner DG
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):139-47. PubMed ID: 9422570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Staging of prostatic adenocarcinoma with radical prostatectomy specimens in Pakistan.
    Memon A; Ahmad Z; Qureshi A; Ahsan A; Barakzai A; Bhurgri Y
    Asian Pac J Cancer Prev; 2009; 10(4):551-4. PubMed ID: 19827867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleolar organizer regions: preliminary results of the clinical use of a new marker for prostatic carcinoma (40 cases).
    Marandola P; Lardennois B; Ploton D; Derenzini M; Treré D; Campo B; Corrada P; Valentino V; Roggia A; Broggini P
    Eur Urol; 1992; 21 Suppl 1():71-4. PubMed ID: 1425841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dr. Donald Floyd Gleason's historic, immense contribution to urologic pathology.
    Filosa A; Fabiani A
    Anal Quant Cytol Histol; 2009 Apr; 31(2):123-4. PubMed ID: 19402390
    [No Abstract]   [Full Text] [Related]  

  • 26. [Staging pelvic lymphadenectomy for carcinoma of the prostate].
    Rinsho K; Ishikawa S; Nemoto R; Koiso K; Takeshima H; Uchida K
    Hinyokika Kiyo; 1985 Sep; 31(9):1583-7. PubMed ID: 4083215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Histologic grading of primary prostatic carcinoma--study of Gleason histologic grading].
    Uchijima Y; Kusuyama H; Okada K
    Hinyokika Kiyo; 1987 Aug; 33(8):1193-8. PubMed ID: 3425519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical and pathological study of prostate cancer using Gleason's classification].
    Nemoto R; Uchida K; Kiriyama I; Koiso K; Harada M
    Nihon Gan Chiryo Gakkai Shi; 1987 Dec; 22(10):2325-30. PubMed ID: 3449581
    [No Abstract]   [Full Text] [Related]  

  • 29. Pattern of prostate cancer among a Nigerian population: A study in a single tertiary care centre.
    Adewumi AO; Anthonia SC; Alabi AS; Amina FO; Kingsley KK
    Niger J Med; 2016; 25(1):70-6. PubMed ID: 29963824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cancer of the prostate: evaluation of the expression of the mutated protein of the 53 tumor suppressor gene].
    Rivera P; Ibacache G; García M; Roa I; Orio M
    Actas Urol Esp; 1997 Oct; 21(9):822-6. PubMed ID: 9471864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gleason's classification of prostatic adenocarcinomas].
    McNeal JE; Gleason DF
    Ann Pathol; 1991; 11(3):163-8. PubMed ID: 1878086
    [No Abstract]   [Full Text] [Related]  

  • 32. Prognostic criteria in patients with stage D2 prostate cancer. Correlation with mean nuclear volume.
    Fujikawa K; Sasaki M; Aoyama T; Itoh T
    Cancer; 1995 Jul; 76(1):91-5. PubMed ID: 8630882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between stage and grade in prostatic adenocarcinoma: a morphometric study.
    Sharkey FE; Dusenbery DM; Moyer JE; Barry JD
    J Urol; 1984 Sep; 132(3):602-5. PubMed ID: 6471204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complete histologic serial sectioning of a prostate gland with adenocarcinoma.
    Humphrey PA
    Am J Surg Pathol; 1993 May; 17(5):468-72. PubMed ID: 8470761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Progression after radical prostatectomy of cancer of the prostate: prognostic criteria and the role of PSA in monitoring].
    Fendler JP; Dujardin T; Bringeon G; Adeleine P; Devonec M; Perrin P
    Prog Urol; 1992 Feb; 2(1):58-65. PubMed ID: 1284386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathologic characteristics of pseudohyperplastic prostatic adenocarcinoma].
    Zhang HZ; Jiang ZM; Shi L
    Zhonghua Bing Li Xue Za Zhi; 2007 Nov; 36(11):742-5. PubMed ID: 18307877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of Prognosis for Prostatic Adenocarcinoma by Combined Histological Grading and Clinical Staging.
    Gleason DF; Mellinger GT;
    J Urol; 2017 Feb; 197(2S):S134-S139. PubMed ID: 28012760
    [No Abstract]   [Full Text] [Related]  

  • 38. [Gleason's system and pelvic lymphadenectomy in the pretherapeutic evaluation of cancer of the prostate. Apropos of 85 cases].
    Luciani L; Coccarelli F; Pusiol T; Piscioli F
    J Urol (Paris); 1988; 94(2):87-9. PubMed ID: 3392408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidentally Detected Adenocarcinoma Prostate in Transurethral Resection of Prostate Specimens: a Hospital Based Study from India.
    Varghese J; Kuruvilla PM; Mehta N; Rathore RS; Babu M; Bansal D; Pillai B; Sam MP; Krishnamorthy H
    Asian Pac J Cancer Prev; 2016; 17(4):2255-8. PubMed ID: 27221926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of poorly differentiated prostatic adenocarcinoma.
    El-Mahdi AM; Oliphant LD; Schellhammer PF
    Urology; 1983 Jun; 21(6):566-9. PubMed ID: 6868227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.